Come up with a name for your new list and we'll add to it:
Vasopharm raised a round of funding on February 11, 2004. Investors include
Bavarian Research Foundation.
Vasopharm is a biopharmaceutical company dedicated to the discovery and development of therapeutics for the treatment of cerebro- and cardiovascular diseases and their consequences. In this area, the …